Yanlin Chen, NA

Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
Shanghai, China (People's Republic)

Disclosure information not submitted.

Presentation(s):

• SUN-209 - Gensci155, A Novel Long-Acting IGF-1 Analog for the Treatment of Severe Primary IGF‑1 Deficiency with Lower Hypoglycemic Risk and Superior Efficacy

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT